FDA STATE_REFERRAL_LETTER - Diabetes Corporation of America - June 10, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This STATE REFERRAL LETTER record concerns Diabetes Corporation of America, with an inspection on June 10, 2017, issued by the Office of Pharmaceutical Quality, covering drugs.

Company: Diabetes Corporation of America
Inspection Date: June 10, 2017
Product Type: Drugs
Office: Office of Pharmaceutical Quality
People: Hoy D. Allen
John W. Diehl (John W. Diehl, M.S.Program Division)
Mark W. Rivero (Compliance Officer)
William S. Boivin (Retired at FDA)
Reginald Dillard

Open in Dashboard

ID · 4f7a853b-bafc-49f5-b6e1-8ef04bd3956f

Violation Codes3

21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A(a)

Full citation text and observation details available on the Dashboard.